ArticleAnnals of gastroenterological surgery2026
Reappraisal of Real-World Management of Acute Cholecystitis in Elderly Patients Based on the Adherence to Tokyo Guidelines 2018 (TG18): A Multicenter Study on Anzu HPB Surgical Meeting.
Article in Annals of gastroenterological surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Although the Tokyo Guidelines 2018 (TG18) recommend optimal management for acute cholecystitis (AC) using an age-adjusted index, the implementation and outcomes of treatment strategies in elderly patients with AC remain unclear. Methods: A total of 461 patients aged ≥ 70 years with AC from five institutions were retrospectively analyzed, including those who underwent early surgery ( Results: Among Grade I/II AC patients, overall complication rates in Groups A, B, and C were 16.4%, 34.0%, and 8.3%, respectively (A vs. B: Conclusion: In the present trial, treatment for AC was consistent with TG18 recommendations in 45% of patients. Compared with TG18-aligned treatment, more conservative treatment was associated with comparable morbidities, while more aggressive treatment was associated with a higher incidence of major morbidities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.